This article reviews the NICE guidelines on childhood bedwetting (nocturnal enuresis) to ensure accurate, evidence-based information. NICE CG111 recommends that first-line treatments for children aged 5 years and over include enuresis alarms and desmopressin, with the choice depending on family preference and individual circumstances. Reward systems, such as star charts, and retention control training are also supported. The guidelines advise against fluid restriction, waking/lifting (lifting the child during the night), and the use of tricyclic antidepressants like imipramine or amitriptyline.
Assessment should include evaluation of daytime symptoms, bowel and bladder function, emotional or behavioural issues, and the impact of bedwetting on the child and family. Referral to specialist care is considered if initial treatments are unsuccessful after approximately 4 weeks, or if there are complicating factors such as persistent daytime wetting, urinary tract infections, or emotional concerns.
Most children outgrow bedwetting naturally, with prevalence decreasing with age. For children under 5, active treatment is generally not recommended unless there are significant impacts on the child’s or family’s wellbeing.
This summary aligns with current NICE guidance and UK clinical practice, emphasizing tailored, evidence-based management strategies.
